Nektar Therapeutics
Closed
57.24 -3.64
Overview
Share price change
24h
Min
57.02
Max
59.59
Income | 4.3M -41M |
|---|---|
Sales | -730K 10M |
EPS | -1.23 |
Profit margin | -400.967 |
Employees | 63 |
EBITDA | -5.5M -42M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +134.33% upside |
Next Earnings | 5 lis 2026 |
|---|
Market Cap | -247M 2.3B |
|---|---|
Previous open | 60.88 |
Previous close | 57.24 |
Nektar Therapeutics Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Nektar Therapeutics Forecast
Price Target
By TipRanks
134.33% upside
12 Months Forecast
Average 139.143 USD 134.33%
High 192 USD
Low 50 USD
Based on 9 Wall Street analysts offering 12 month price targets forNektar Therapeutics - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$